A sponsor selected us to provide patient engagement services for an early-phase knee osteoarthritis pain study. We were selected due to extensive experience in regenerative medicine, dedication to advancement of FDA regulated treatments, and our shared commitment to research sites.
Our team brought in 1,321 leads for the sponsor and pre-screened over 1,317 leads. Due to our efforts, the sites were able to account for over 10% of the entire study enrollment goal.